Tang Carolyn C. 4
4 · Arcus Biosciences, Inc. · Filed Jun 21, 2022
Insider Transaction Report
Form 4
Tang Carolyn C.
General Counsel
Transactions
- Sale
Common Stock
2022-06-17$22.29/sh−1,073$23,917→ 23,909 total - Sale
Common Stock
2022-06-16$20.72/sh−1,400$29,008→ 25,431 total - Sale
Common Stock
2022-06-17$21.71/sh−449$9,748→ 24,982 total
Footnotes (5)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.33 to $21.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Includes 1,017 shares purchased on 5/31/2022 through the Company's Employee Stock Purchase Plan
- [F4]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.14 to $22.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F5]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.14 to $22.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.